id	sid	tid	token	lemma	pos
dpc-1329	1	1	dermatology	dermatology	NOUN
dpc-1329	1	2	:	:	PUNCT
dpc-1329	1	3	practical	practical	ADJ
dpc-1329	1	4	and	and	CCONJ
dpc-1329	1	5	conceptual	conceptual	ADJ
dpc-1329	1	6	letter	letter	NOUN
dpc-1329	2	1	|	|	ADV
dpc-1329	2	2	dermatol	dermatol	ADJ
dpc-1329	2	3	pract	pract	NOUN
dpc-1329	2	4	concept	concept	NOUN
dpc-1329	2	5	2021;11(2):e2021008	2021;11(2):e2021008	NUM
dpc-1329	2	6	1	1	NUM
dpc-1329	2	7	dermatology	dermatology	NOUN
dpc-1329	2	8	practical	practical	ADJ
dpc-1329	2	9	&	&	CCONJ
dpc-1329	2	10	conceptual	conceptual	ADJ
dpc-1329	2	11	acne	acne	PROPN
dpc-1329	2	12	inversa	inversa	NOUN
dpc-1329	2	13	-	-	PUNCT
dpc-1329	2	14	like	like	ADJ
dpc-1329	2	15	lesions	lesion	NOUN
dpc-1329	2	16	induced	induce	VERB
dpc-1329	2	17	by	by	ADP
dpc-1329	2	18	a	a	DET
dpc-1329	2	19	low	low	ADJ
dpc-1329	2	20	dose	dose	NOUN
dpc-1329	2	21	of	of	ADP
dpc-1329	2	22	 	 	SPACE
dpc-1329	2	23	sorafenib	sorafenib	NOUN
dpc-1329	2	24	javier	javier	PROPN
dpc-1329	2	25	aubán	aubán	PROPN
dpc-1329	2	26	-	-	PUNCT
dpc-1329	2	27	pariente1	pariente1	NOUN
dpc-1329	2	28	,	,	PUNCT
dpc-1329	2	29	laura	laura	PROPN
dpc-1329	2	30	palacios	palacios	PROPN
dpc-1329	2	31	-	-	PUNCT
dpc-1329	2	32	garcía1	garcía1	PROPN
dpc-1329	2	33	,	,	PUNCT
dpc-1329	2	34	cristina	cristina	PROPN
dpc-1329	2	35	galache	galache	PROPN
dpc-1329	2	36	-	-	PUNCT
dpc-1329	2	37	osuna1	osuna1	PROPN
dpc-1329	2	38	,	,	PUNCT
dpc-1329	2	39	marc	marc	PROPN
dpc-1329	2	40	mir	mir	PROPN
dpc-1329	2	41	-	-	PUNCT
dpc-1329	2	42	bonafé1	bonafé1	PROPN
dpc-1329	2	43	,	,	PUNCT
dpc-1329	2	44	patricia	patricia	PROPN
dpc-1329	2	45	morales	morales	PROPN
dpc-1329	2	46	del	del	PROPN
dpc-1329	2	47	burgo2	burgo2	PROPN
dpc-1329	2	48	,	,	PUNCT
dpc-1329	2	49	jorge	jorge	PROPN
dpc-1329	2	50	santos	santos	PROPN
dpc-1329	2	51	-	-	PUNCT
dpc-1329	2	52	juanes1	juanes1	PROPN
dpc-1329	2	53	1	1	NUM
dpc-1329	2	54	department	department	NOUN
dpc-1329	2	55	of	of	ADP
dpc-1329	2	56	dermatology	dermatology	NOUN
dpc-1329	2	57	,	,	PUNCT
dpc-1329	2	58	central	central	ADJ
dpc-1329	2	59	university	university	NOUN
dpc-1329	2	60	hospital	hospital	NOUN
dpc-1329	2	61	 	 	SPACE
dpc-1329	2	62	of	of	ADP
dpc-1329	2	63	 	 	SPACE
dpc-1329	2	64	asturias	asturias	PROPN
dpc-1329	2	65	,	,	PUNCT
dpc-1329	2	66	oviedo	oviedo	PROPN
dpc-1329	2	67	,	,	PUNCT
dpc-1329	2	68	spain	spain	PROPN
dpc-1329	2	69	2	2	NUM
dpc-1329	2	70	department	department	NOUN
dpc-1329	2	71	of	of	ADP
dpc-1329	2	72	pathology	pathology	PROPN
dpc-1329	2	73	,	,	PUNCT
dpc-1329	2	74	central	central	ADJ
dpc-1329	2	75	university	university	NOUN
dpc-1329	2	76	hospital	hospital	NOUN
dpc-1329	2	77	 	 	SPACE
dpc-1329	2	78	of	of	ADP
dpc-1329	2	79	 	 	SPACE
dpc-1329	2	80	asturias	asturias	PROPN
dpc-1329	2	81	,	,	PUNCT
dpc-1329	2	82	oviedo	oviedo	PROPN
dpc-1329	2	83	,	,	PUNCT
dpc-1329	2	84	spain	spain	PROPN
dpc-1329	2	85	key	key	ADJ
dpc-1329	2	86	words	word	NOUN
dpc-1329	2	87	:	:	PUNCT
dpc-1329	2	88	acne	acne	NOUN
dpc-1329	2	89	inversa	inversa	NOUN
dpc-1329	2	90	,	,	PUNCT
dpc-1329	2	91	sorafenib	sorafenib	NOUN
dpc-1329	2	92	,	,	PUNCT
dpc-1329	2	93	cutaneous	cutaneous	ADJ
dpc-1329	2	94	adverse	adverse	ADJ
dpc-1329	2	95	reactions	reaction	NOUN
dpc-1329	2	96	,	,	PUNCT
dpc-1329	2	97	dermatopathology	dermatopathology	NOUN
dpc-1329	2	98	citation	citation	NOUN
dpc-1329	2	99	:	:	PUNCT
dpc-1329	2	100	aubán	aubán	ADJ
dpc-1329	2	101	-	-	PUNCT
dpc-1329	2	102	pariente	pariente	NOUN
dpc-1329	2	103	j	j	PROPN
dpc-1329	2	104	,	,	PUNCT
dpc-1329	2	105	palacios	palacio	NOUN
dpc-1329	2	106	-	-	PUNCT
dpc-1329	2	107	garcía	garcía	ADJ
dpc-1329	2	108	l	l	NOUN
dpc-1329	2	109	,	,	PUNCT
dpc-1329	2	110	galache	galache	NOUN
dpc-1329	2	111	-	-	PUNCT
dpc-1329	2	112	osuna	osuna	PROPN
dpc-1329	2	113	c	c	X
dpc-1329	2	114	,	,	PUNCT
dpc-1329	2	115	mir	mir	ADJ
dpc-1329	2	116	-	-	ADJ
dpc-1329	2	117	bonafé	bonafé	NOUN
dpc-1329	2	118	m.	m.	NOUN
dpc-1329	2	119	morales	morales	PROPN
dpc-1329	2	120	del	del	PROPN
dpc-1329	2	121	burgo	burgo	PROPN
dpc-1329	2	122	p	p	X
dpc-1329	2	123	,	,	PUNCT
dpc-1329	2	124	santos	santos	PROPN
dpc-1329	2	125	-	-	PUNCT
dpc-1329	2	126	juanes	juanes	PROPN
dpc-1329	2	127	j.	j.	PROPN
dpc-1329	2	128	acne	acne	PROPN
dpc-1329	2	129	inversa	inversa	PROPN
dpc-1329	2	130	-	-	PUNCT
dpc-1329	2	131	like	like	ADJ
dpc-1329	2	132	lesions	lesion	NOUN
dpc-1329	2	133	induced	induce	VERB
dpc-1329	2	134	by	by	ADP
dpc-1329	2	135	a	a	DET
dpc-1329	2	136	low	low	ADJ
dpc-1329	2	137	dose	dose	NOUN
dpc-1329	2	138	of	of	ADP
dpc-1329	2	139	sorafenib	sorafenib	NOUN
dpc-1329	2	140	.	.	PUNCT
dpc-1329	3	1	dermatol	dermatol	NOUN
dpc-1329	3	2	pract	pract	PROPN
dpc-1329	3	3	concept	concept	NOUN
dpc-1329	3	4	.	.	PUNCT
dpc-1329	4	1	2021;11(2):e2021008	2021;11(2):e2021008	X
dpc-1329	4	2	.	.	PUNCT
dpc-1329	4	3	doi	doi	NOUN
dpc-1329	4	4	:	:	PUNCT
dpc-1329	4	5	https://doi.org/10.5826/dpc.1102a08	https://doi.org/10.5826/dpc.1102a08	PROPN
dpc-1329	4	6	accepted	accept	VERB
dpc-1329	4	7	:	:	PUNCT
dpc-1329	4	8	july	july	PROPN
dpc-1329	4	9	29	29	NUM
dpc-1329	4	10	,	,	PUNCT
dpc-1329	4	11	2020	2020	NUM
dpc-1329	4	12	;	;	PUNCT
dpc-1329	4	13	published	publish	VERB
dpc-1329	4	14	:	:	PUNCT
dpc-1329	4	15	march	march	PROPN
dpc-1329	4	16	8	8	NUM
dpc-1329	4	17	,	,	PUNCT
dpc-1329	4	18	2021	2021	NUM
dpc-1329	4	19	copyright	copyright	NOUN
dpc-1329	4	20	:	:	PUNCT
dpc-1329	5	1	©	©	PROPN
dpc-1329	5	2	2021	2021	NUM
dpc-1329	5	3	aubán	aubán	ADJ
dpc-1329	5	4	-	-	PUNCT
dpc-1329	5	5	pariente	pariente	NOUN
dpc-1329	5	6	et	et	PROPN
dpc-1329	5	7	al	al	PROPN
dpc-1329	5	8	.	.	PUNCT
dpc-1329	6	1	this	this	PRON
dpc-1329	6	2	is	be	AUX
dpc-1329	6	3	an	an	DET
dpc-1329	6	4	open	open	ADJ
dpc-1329	6	5	-	-	PUNCT
dpc-1329	6	6	access	access	NOUN
dpc-1329	6	7	article	article	NOUN
dpc-1329	6	8	distributed	distribute	VERB
dpc-1329	6	9	under	under	ADP
dpc-1329	6	10	the	the	DET
dpc-1329	6	11	terms	term	NOUN
dpc-1329	6	12	of	of	ADP
dpc-1329	6	13	the	the	DET
dpc-1329	6	14	creative	creative	ADJ
dpc-1329	6	15	commons	common	NOUN
dpc-1329	6	16	attribution	attribution	NOUN
dpc-1329	6	17	license	license	NOUN
dpc-1329	6	18	by	by	ADP
dpc-1329	6	19	-	-	PUNCT
dpc-1329	6	20	nc-4.0	nc-4.0	NOUN
dpc-1329	6	21	,	,	PUNCT
dpc-1329	6	22	which	which	PRON
dpc-1329	6	23	permits	permit	VERB
dpc-1329	6	24	unrestricted	unrestricted	ADJ
dpc-1329	6	25	noncommercial	noncommercial	ADJ
dpc-1329	6	26	use	use	NOUN
dpc-1329	6	27	,	,	PUNCT
dpc-1329	6	28	distribution	distribution	NOUN
dpc-1329	6	29	,	,	PUNCT
dpc-1329	6	30	and	and	CCONJ
dpc-1329	6	31	reproduction	reproduction	NOUN
dpc-1329	6	32	in	in	ADP
dpc-1329	6	33	any	any	DET
dpc-1329	6	34	medium	medium	NOUN
dpc-1329	6	35	,	,	PUNCT
dpc-1329	6	36	provided	provide	VERB
dpc-1329	6	37	the	the	DET
dpc-1329	6	38	original	original	ADJ
dpc-1329	6	39	author	author	NOUN
dpc-1329	6	40	and	and	CCONJ
dpc-1329	6	41	source	source	NOUN
dpc-1329	6	42	are	be	AUX
dpc-1329	6	43	credited	credit	VERB
dpc-1329	6	44	.	.	PUNCT
dpc-1329	7	1	funding	funding	NOUN
dpc-1329	7	2	:	:	PUNCT
dpc-1329	7	3	none	none	NOUN
dpc-1329	7	4	.	.	PUNCT
dpc-1329	8	1	competing	compete	VERB
dpc-1329	8	2	interests	interest	NOUN
dpc-1329	8	3	:	:	PUNCT
dpc-1329	8	4	the	the	DET
dpc-1329	8	5	authors	author	NOUN
dpc-1329	8	6	have	have	VERB
dpc-1329	8	7	no	no	DET
dpc-1329	8	8	conflicts	conflict	NOUN
dpc-1329	8	9	of	of	ADP
dpc-1329	8	10	interest	interest	NOUN
dpc-1329	8	11	to	to	PART
dpc-1329	8	12	disclose	disclose	VERB
dpc-1329	8	13	.	.	PUNCT
dpc-1329	9	1	authorship	authorship	NOUN
dpc-1329	9	2	:	:	PUNCT
dpc-1329	9	3	all	all	DET
dpc-1329	9	4	authors	author	NOUN
dpc-1329	9	5	have	have	AUX
dpc-1329	9	6	contributed	contribute	VERB
dpc-1329	9	7	significantly	significantly	ADV
dpc-1329	9	8	to	to	ADP
dpc-1329	9	9	this	this	DET
dpc-1329	9	10	publication	publication	NOUN
dpc-1329	9	11	.	.	PUNCT
dpc-1329	10	1	corresponding	correspond	VERB
dpc-1329	10	2	author	author	NOUN
dpc-1329	10	3	:	:	PUNCT
dpc-1329	10	4	javier	javier	PROPN
dpc-1329	10	5	aubán	aubán	ADJ
dpc-1329	10	6	-	-	PUNCT
dpc-1329	10	7	pariente	pariente	NOUN
dpc-1329	10	8	,	,	PUNCT
dpc-1329	10	9	md	md	PROPN
dpc-1329	10	10	,	,	PUNCT
dpc-1329	10	11	central	central	ADJ
dpc-1329	10	12	university	university	NOUN
dpc-1329	10	13	hospital	hospital	NOUN
dpc-1329	10	14	 	 	SPACE
dpc-1329	10	15	of	of	ADP
dpc-1329	10	16	 	 	SPACE
dpc-1329	10	17	asturias	asturias	PROPN
dpc-1329	10	18	,	,	PUNCT
dpc-1329	10	19	dermatology	dermatology	NOUN
dpc-1329	10	20	department	department	NOUN
dpc-1329	10	21	,	,	PUNCT
dpc-1329	10	22	av	av	PROPN
dpc-1329	10	23	.	.	PUNCT
dpc-1329	10	24	roma	roma	PROPN
dpc-1329	10	25	,	,	PUNCT
dpc-1329	10	26	s	s	PROPN
dpc-1329	10	27	/	/	SYM
dpc-1329	10	28	n	n	CCONJ
dpc-1329	10	29	,	,	PUNCT
dpc-1329	10	30	33011	33011	NUM
dpc-1329	10	31	oviedo	oviedo	PROPN
dpc-1329	10	32	,	,	PUNCT
dpc-1329	10	33	spain	spain	PROPN
dpc-1329	10	34	.	.	PUNCT
dpc-1329	11	1	tel	tel	PROPN
dpc-1329	11	2	.	.	PROPN
dpc-1329	11	3	34	34	NUM
dpc-1329	11	4	-	-	SYM
dpc-1329	11	5	985108000	985108000	NUM
dpc-1329	11	6	.	.	PUNCT
dpc-1329	12	1	email	email	NOUN
dpc-1329	12	2	:	:	PUNCT
dpc-1329	13	1	javiauban@gmail.com	javiauban@gmail.com	X
dpc-1329	13	2	introduction	introduction	NOUN
dpc-1329	13	3	sorafenib	sorafenib	NOUN
dpc-1329	13	4	is	be	AUX
dpc-1329	13	5	an	an	DET
dpc-1329	13	6	oral	oral	ADJ
dpc-1329	13	7	multikinase	multikinase	NOUN
dpc-1329	13	8	inhibitor	inhibitor	NOUN
dpc-1329	13	9	approved	approve	VERB
dpc-1329	13	10	for	for	ADP
dpc-1329	13	11	the	the	DET
dpc-1329	13	12	treatment	treatment	NOUN
dpc-1329	13	13	of	of	ADP
dpc-1329	13	14	unresectable	unresectable	ADJ
dpc-1329	13	15	hepatocellular	hepatocellular	ADJ
dpc-1329	13	16	carcinoma	carcinoma	NOUN
dpc-1329	13	17	,	,	PUNCT
dpc-1329	13	18	differentiated	differentiated	ADJ
dpc-1329	13	19	thyroid	thyroid	NOUN
dpc-1329	13	20	cancer	cancer	NOUN
dpc-1329	13	21	,	,	PUNCT
dpc-1329	13	22	and	and	CCONJ
dpc-1329	13	23	advanced	advanced	ADJ
dpc-1329	13	24	renal	renal	ADJ
dpc-1329	13	25	-	-	PUNCT
dpc-1329	13	26	cell	cell	NOUN
dpc-1329	13	27	carcinoma	carcinoma	NOUN
dpc-1329	13	28	.	.	PUNCT
dpc-1329	14	1	this	this	DET
dpc-1329	14	2	drug	drug	NOUN
dpc-1329	14	3	 	 	SPACE
dpc-1329	14	4	blocks	block	NOUN
dpc-1329	14	5	 	 	SPACE
dpc-1329	14	6	tumor	tumor	NOUN
dpc-1329	14	7	cell	cell	NOUN
dpc-1329	14	8	proliferation	proliferation	NOUN
dpc-1329	14	9	and	and	CCONJ
dpc-1329	14	10	angiogenesis	angiogenesis	NOUN
dpc-1329	14	11	by	by	ADP
dpc-1329	14	12	inhibiting	inhibit	VERB
dpc-1329	14	13	the	the	DET
dpc-1329	14	14	raf	raf	PROPN
dpc-1329	14	15	serine	serine	NOUN
dpc-1329	14	16	/	/	SYM
dpc-1329	14	17	threonine	threonine	ADJ
dpc-1329	14	18	kinases	kinase	NOUN
dpc-1329	14	19	(	(	PUNCT
dpc-1329	14	20	raf1	raf1	ADJ
dpc-1329	14	21	and	and	CCONJ
dpc-1329	14	22	braf	braf	NOUN
dpc-1329	14	23	)	)	PUNCT
dpc-1329	14	24	as	as	ADV
dpc-1329	14	25	well	well	ADV
dpc-1329	14	26	as	as	ADP
dpc-1329	14	27	multiple	multiple	ADJ
dpc-1329	14	28	receptor	receptor	NOUN
dpc-1329	14	29	tyrosine	tyrosine	NOUN
dpc-1329	14	30	kinases	kinase	NOUN
dpc-1329	15	1	[	[	X
dpc-1329	15	2	1	1	NUM
dpc-1329	15	3	]	]	PUNCT
dpc-1329	15	4	.	.	PUNCT
dpc-1329	16	1	adverse	adverse	ADJ
dpc-1329	16	2	skin	skin	NOUN
dpc-1329	16	3	reactions	reaction	NOUN
dpc-1329	16	4	 	 	SPACE
dpc-1329	16	5	occur	occur	VERB
dpc-1329	16	6	in	in	ADP
dpc-1329	16	7	 	 	SPACE
dpc-1329	16	8	up	up	ADP
dpc-1329	16	9	to	to	PART
dpc-1329	16	10	90	90	NUM
dpc-1329	16	11	%	%	NOUN
dpc-1329	16	12	of	of	ADP
dpc-1329	16	13	 	 	SPACE
dpc-1329	16	14	patients	patient	NOUN
dpc-1329	16	15	.	.	PUNCT
dpc-1329	17	1	although	although	SCONJ
dpc-1329	17	2	acneiform	acneiform	ADJ
dpc-1329	17	3	eruptions	eruption	NOUN
dpc-1329	17	4	have	have	AUX
dpc-1329	17	5	been	be	AUX
dpc-1329	17	6	widely	widely	ADV
dpc-1329	17	7	reported	report	VERB
dpc-1329	17	8	in	in	ADP
dpc-1329	17	9	association	association	NOUN
dpc-1329	17	10	with	with	ADP
dpc-1329	17	11	epidermal	epidermal	ADJ
dpc-1329	17	12	growth	growth	NOUN
dpc-1329	17	13	factor	factor	NOUN
dpc-1329	17	14	receptor	receptor	NOUN
dpc-1329	17	15	 	 	SPACE
dpc-1329	17	16	(	(	PUNCT
dpc-1329	17	17	egfr	egfr	X
dpc-1329	17	18	)	)	PUNCT
dpc-1329	17	19	inhibition	inhibition	NOUN
dpc-1329	17	20	,	,	PUNCT
dpc-1329	17	21	ranging	range	VERB
dpc-1329	17	22	from	from	ADP
dpc-1329	17	23	24%-91	24%-91	NUM
dpc-1329	17	24	%	%	NOUN
dpc-1329	17	25	of	of	ADP
dpc-1329	17	26	patients	patient	NOUN
dpc-1329	17	27	,	,	PUNCT
dpc-1329	17	28	those	those	PRON
dpc-1329	17	29	induced	induce	VERB
dpc-1329	17	30	by	by	ADP
dpc-1329	17	31	sorafenib	sorafenib	NOUN
dpc-1329	17	32	are	be	AUX
dpc-1329	17	33	rare	rare	ADJ
dpc-1329	17	34	.	.	PUNCT
dpc-1329	18	1	they	they	PRON
dpc-1329	18	2	usually	usually	ADV
dpc-1329	18	3	appear	appear	VERB
dpc-1329	18	4	in	in	ADP
dpc-1329	18	5	the	the	DET
dpc-1329	18	6	first	first	ADJ
dpc-1329	18	7	6	6	NUM
dpc-1329	18	8	weeks	week	NOUN
dpc-1329	18	9	after	after	SCONJ
dpc-1329	18	10	drug	drug	NOUN
dpc-1329	18	11	onset	onset	NOUN
dpc-1329	18	12	and	and	CCONJ
dpc-1329	18	13	are	be	AUX
dpc-1329	18	14	located	locate	VERB
dpc-1329	18	15	on	on	ADP
dpc-1329	18	16	the	the	DET
dpc-1329	18	17	face	face	NOUN
dpc-1329	18	18	.	.	PUNCT
dpc-1329	19	1	regarding	regard	VERB
dpc-1329	19	2	clinical	clinical	ADJ
dpc-1329	19	3	-	-	PUNCT
dpc-1329	19	4	pathological	pathological	ADJ
dpc-1329	19	5	characteristics	characteristic	NOUN
dpc-1329	19	6	,	,	PUNCT
dpc-1329	19	7	acneiform	acneiform	ADJ
dpc-1329	19	8	eruptions	eruption	NOUN
dpc-1329	19	9	induced	induce	VERB
dpc-1329	19	10	by	by	ADP
dpc-1329	19	11	sorafenib	sorafenib	NOUN
dpc-1329	19	12	are	be	AUX
dpc-1329	19	13	classified	classify	VERB
dpc-1329	19	14	into	into	ADP
dpc-1329	19	15	3	3	NUM
dpc-1329	19	16	groups	group	NOUN
dpc-1329	19	17	:	:	PUNCT
dpc-1329	19	18	papulopustular	papulopustular	ADJ
dpc-1329	19	19	eruptions	eruption	NOUN
dpc-1329	19	20	without	without	ADP
dpc-1329	19	21	associated	associated	ADJ
dpc-1329	19	22	retention	retention	NOUN
dpc-1329	19	23	lesions	lesion	NOUN
dpc-1329	19	24	,	,	PUNCT
dpc-1329	19	25	nodular	nodular	ADJ
dpc-1329	19	26	-	-	PUNCT
dpc-1329	19	27	cystic	cystic	ADJ
dpc-1329	19	28	eruptions	eruption	NOUN
dpc-1329	19	29	,	,	PUNCT
dpc-1329	19	30	and	and	CCONJ
dpc-1329	19	31	perforating	perforate	VERB
dpc-1329	19	32	folliculitis	folliculitis	NOUN
dpc-1329	19	33	[	[	X
dpc-1329	19	34	2	2	NUM
dpc-1329	19	35	]	]	PUNCT
dpc-1329	19	36	.	.	PUNCT
dpc-1329	20	1	of	of	ADP
dpc-1329	20	2	these	these	DET
dpc-1329	20	3	groups	group	NOUN
dpc-1329	20	4	,	,	PUNCT
dpc-1329	20	5	papulopustular	papulopustular	ADJ
dpc-1329	20	6	facial	facial	ADJ
dpc-1329	20	7	eruptions	eruption	NOUN
dpc-1329	20	8	have	have	AUX
dpc-1329	20	9	been	be	AUX
dpc-1329	20	10	the	the	DET
dpc-1329	20	11	most	most	ADV
dpc-1329	20	12	frequently	frequently	ADV
dpc-1329	20	13	observed	observe	VERB
dpc-1329	20	14	.	.	PUNCT
dpc-1329	21	1	here	here	ADV
dpc-1329	21	2	we	we	PRON
dpc-1329	21	3	report	report	VERB
dpc-1329	21	4	a	a	DET
dpc-1329	21	5	case	case	NOUN
dpc-1329	21	6	of	of	ADP
dpc-1329	21	7	acne	acne	NOUN
dpc-1329	21	8	inversa	inversa	NOUN
dpc-1329	21	9	-	-	PUNCT
dpc-1329	21	10	like	like	ADJ
dpc-1329	21	11	lesions	lesion	NOUN
dpc-1329	21	12	induced	induce	VERB
dpc-1329	21	13	by	by	ADP
dpc-1329	21	14	a	a	DET
dpc-1329	21	15	low	low	ADJ
dpc-1329	21	16	dose	dose	NOUN
dpc-1329	21	17	of	of	ADP
dpc-1329	21	18	sorafenib	sorafenib	NOUN
dpc-1329	21	19	in	in	ADP
dpc-1329	21	20	a	a	DET
dpc-1329	21	21	62	62	NUM
dpc-1329	21	22	-	-	PUNCT
dpc-1329	21	23	year	year	NOUN
dpc-1329	21	24	-	-	PUNCT
dpc-1329	21	25	old	old	ADJ
dpc-1329	21	26	man	man	NOUN
dpc-1329	21	27	with	with	ADP
dpc-1329	21	28	hepatocellular	hepatocellular	ADJ
dpc-1329	21	29	carcinoma	carcinoma	NOUN
dpc-1329	21	30	.	.	PUNCT
dpc-1329	22	1	case	case	NOUN
dpc-1329	22	2	presentation	presentation	NOUN
dpc-1329	22	3	a	a	DET
dpc-1329	22	4	62	62	NUM
dpc-1329	22	5	-	-	PUNCT
dpc-1329	22	6	year	year	NOUN
dpc-1329	22	7	-	-	PUNCT
dpc-1329	22	8	old	old	ADJ
dpc-1329	22	9	man	man	NOUN
dpc-1329	22	10	was	be	AUX
dpc-1329	22	11	referred	refer	VERB
dpc-1329	22	12	to	to	ADP
dpc-1329	22	13	us	we	PRON
dpc-1329	22	14	for	for	ADP
dpc-1329	22	15	evaluation	evaluation	NOUN
dpc-1329	22	16	of	of	ADP
dpc-1329	22	17	2	2	NUM
dpc-1329	22	18	exudative	exudative	ADJ
dpc-1329	22	19	lesions	lesion	NOUN
dpc-1329	22	20	on	on	ADP
dpc-1329	22	21	his	his	PRON
dpc-1329	22	22	lower	low	ADJ
dpc-1329	22	23	extremities	extremity	NOUN
dpc-1329	22	24	of	of	ADP
dpc-1329	22	25	1	1	NUM
dpc-1329	22	26	-	-	PUNCT
dpc-1329	22	27	month	month	NOUN
dpc-1329	22	28	duration	duration	NOUN
dpc-1329	22	29	.	.	PUNCT
dpc-1329	23	1	his	his	PRON
dpc-1329	23	2	medical	medical	ADJ
dpc-1329	23	3	history	history	NOUN
dpc-1329	23	4	included	include	VERB
dpc-1329	23	5	sorafenib	sorafenib	NOUN
dpc-1329	23	6	400	400	NUM
dpc-1329	23	7	mg	mg	NUM
dpc-1329	23	8	/	/	SYM
dpc-1329	23	9	day	day	NOUN
dpc-1329	23	10	for	for	ADP
dpc-1329	23	11	4	4	NUM
dpc-1329	23	12	months	month	NOUN
dpc-1329	23	13	for	for	ADP
dpc-1329	23	14	diffuse	diffuse	ADJ
dpc-1329	23	15	hepatocellular	hepatocellular	ADJ
dpc-1329	23	16	carcinoma	carcinoma	NOUN
dpc-1329	23	17	.	.	PUNCT
dpc-1329	24	1	the	the	DET
dpc-1329	24	2	patient	patient	NOUN
dpc-1329	24	3	denied	deny	VERB
dpc-1329	24	4	a	a	DET
dpc-1329	24	5	history	history	NOUN
dpc-1329	24	6	of	of	ADP
dpc-1329	24	7	similar	similar	ADJ
dpc-1329	24	8	lesions	lesion	NOUN
dpc-1329	24	9	prior	prior	ADV
dpc-1329	24	10	to	to	ADP
dpc-1329	24	11	the	the	DET
dpc-1329	24	12	onset	onset	NOUN
dpc-1329	24	13	of	of	ADP
dpc-1329	24	14	sorafenib	sorafenib	NOUN
dpc-1329	24	15	.	.	PUNCT
dpc-1329	25	1	physical	physical	ADJ
dpc-1329	25	2	examination	examination	NOUN
dpc-1329	25	3	revealed	reveal	VERB
dpc-1329	25	4	2	2	NUM
dpc-1329	25	5	indurated	indurate	VERB
dpc-1329	25	6	erythematous	erythematous	ADJ
dpc-1329	25	7	plaques	plaque	NOUN
dpc-1329	25	8	on	on	ADP
dpc-1329	25	9	both	both	DET
dpc-1329	25	10	thighs	thigh	NOUN
dpc-1329	25	11	that	that	PRON
dpc-1329	25	12	were	be	AUX
dpc-1329	25	13	2	2	NUM
dpc-1329	25	14	to	to	PART
dpc-1329	25	15	6	6	NUM
dpc-1329	25	16	 	 	SPACE
dpc-1329	25	17	cm	cm	NOUN
dpc-1329	25	18	in	in	ADP
dpc-1329	25	19	diameter	diameter	NOUN
dpc-1329	25	20	(	(	PUNCT
dpc-1329	25	21	figure	figure	NOUN
dpc-1329	25	22	1	1	NUM
dpc-1329	25	23	,	,	PUNCT
dpc-1329	25	24	a	a	PRON
dpc-1329	25	25	and	and	CCONJ
dpc-1329	25	26	b	b	NOUN
dpc-1329	25	27	)	)	PUNCT
dpc-1329	25	28	.	.	PUNCT
dpc-1329	26	1	the	the	DET
dpc-1329	26	2	lesions	lesion	NOUN
dpc-1329	26	3	had	have	VERB
dpc-1329	26	4	small	small	ADJ
dpc-1329	26	5	oozing	oozing	ADJ
dpc-1329	26	6	cavities	cavity	NOUN
dpc-1329	26	7	,	,	PUNCT
dpc-1329	26	8	fistulous	fistulous	ADJ
dpc-1329	26	9	tracts	tract	NOUN
dpc-1329	26	10	,	,	PUNCT
dpc-1329	26	11	and	and	CCONJ
dpc-1329	26	12	depressed	depressed	ADJ
dpc-1329	26	13	scar	scar	NOUN
dpc-1329	26	14	areas	area	NOUN
dpc-1329	26	15	.	.	PUNCT
dpc-1329	27	1	no	no	DET
dpc-1329	27	2	involvement	involvement	NOUN
dpc-1329	27	3	of	of	ADP
dpc-1329	27	4	other	other	ADJ
dpc-1329	27	5	locations	location	NOUN
dpc-1329	27	6	was	be	AUX
dpc-1329	27	7	observed	observe	VERB
dpc-1329	27	8	.	.	PUNCT
dpc-1329	28	1	skin	skin	NOUN
dpc-1329	28	2	swabs	swab	NOUN
dpc-1329	28	3	for	for	ADP
dpc-1329	28	4	viral	viral	ADJ
dpc-1329	28	5	and	and	CCONJ
dpc-1329	28	6	bacterial	bacterial	ADJ
dpc-1329	28	7	cultures	culture	NOUN
dpc-1329	28	8	were	be	AUX
dpc-1329	28	9	negative	negative	ADJ
dpc-1329	28	10	.	.	PUNCT
dpc-1329	29	1	a	a	DET
dpc-1329	29	2	skin	skin	NOUN
dpc-1329	29	3	biopsy	biopsy	NOUN
dpc-1329	29	4	showed	show	VERB
dpc-1329	29	5	perifollicular	perifollicular	ADJ
dpc-1329	29	6	and	and	CCONJ
dpc-1329	29	7	perivascular	perivascular	ADJ
dpc-1329	29	8	lymphohistiocytic	lymphohistiocytic	ADJ
dpc-1329	29	9	infiltration	infiltration	NOUN
dpc-1329	29	10	(	(	PUNCT
dpc-1329	29	11	figure	figure	NOUN
dpc-1329	29	12	2a	2a	NUM
dpc-1329	29	13	)	)	PUNCT
dpc-1329	29	14	.	.	PUNCT
dpc-1329	30	1	dilated	dilate	VERB
dpc-1329	30	2	follicular	follicular	ADJ
dpc-1329	30	3	infundibula	infundibula	NOUN
dpc-1329	30	4	were	be	AUX
dpc-1329	30	5	filled	fill	VERB
dpc-1329	30	6	with	with	ADP
dpc-1329	30	7	compact	compact	ADJ
dpc-1329	30	8	parakeratotic	parakeratotic	ADJ
dpc-1329	30	9	cornified	cornifie	VERB
dpc-1329	30	10	cells	cell	NOUN
dpc-1329	30	11	and	and	CCONJ
dpc-1329	30	12	neutrophils	neutrophil	NOUN
dpc-1329	30	13	(	(	PUNCT
dpc-1329	30	14	figure	figure	NOUN
dpc-1329	30	15	2b	2b	NOUN
dpc-1329	30	16	)	)	PUNCT
dpc-1329	30	17	.	.	PUNCT
dpc-1329	31	1	a	a	DET
dpc-1329	31	2	diagnosis	diagnosis	NOUN
dpc-1329	31	3	of	of	ADP
dpc-1329	31	4	acne	acne	NOUN
dpc-1329	31	5	inversa	inversa	NOUN
dpc-1329	31	6	-	-	PUNCT
dpc-1329	31	7	like	like	ADJ
dpc-1329	31	8	lesions	lesion	NOUN
dpc-1329	31	9	induced	induce	VERB
dpc-1329	31	10	by	by	ADP
dpc-1329	31	11	sorafenib	sorafenib	NOUN
dpc-1329	31	12	was	be	AUX
dpc-1329	31	13	made	make	VERB
dpc-1329	31	14	,	,	PUNCT
dpc-1329	31	15	and	and	CCONJ
dpc-1329	31	16	topic	topic	NOUN
dpc-1329	31	17	2	2	NUM
dpc-1329	31	18	letter	letter	NOUN
dpc-1329	31	19	|	|	ADV
dpc-1329	31	20	dermatol	dermatol	ADJ
dpc-1329	31	21	pract	pract	NOUN
dpc-1329	31	22	concept	concept	NOUN
dpc-1329	31	23	2021;11(2):e2021008	2021;11(2):e2021008	NUM
dpc-1329	31	24	references	reference	NOUN
dpc-1329	31	25	1	1	NUM
dpc-1329	31	26	.	.	PUNCT
dpc-1329	31	27	pichler	pichler	PROPN
dpc-1329	31	28	m	m	PROPN
dpc-1329	31	29	,	,	PUNCT
dpc-1329	31	30	carriere	carriere	PROPN
dpc-1329	31	31	c	c	PROPN
dpc-1329	31	32	,	,	PUNCT
dpc-1329	31	33	mazzoleni	mazzoleni	NOUN
dpc-1329	31	34	g	g	NOUN
dpc-1329	31	35	,	,	PUNCT
dpc-1329	31	36	kluge	kluge	ADJ
dpc-1329	31	37	r	r	NOUN
dpc-1329	31	38	,	,	PUNCT
dpc-1329	31	39	eisendle	eisendle	PROPN
dpc-1329	31	40	k.	k.	PROPN
dpc-1329	31	41	acne	acne	PROPN
dpc-1329	31	42	inversa	inversa	PROPN
dpc-1329	31	43	-	-	PUNCT
dpc-1329	31	44	like	like	ADJ
dpc-1329	31	45	lesions	lesion	NOUN
dpc-1329	31	46	associated	associate	VERB
dpc-1329	31	47	with	with	ADP
dpc-1329	31	48	the	the	DET
dpc-1329	31	49	multi	multi	ADJ
dpc-1329	31	50	-	-	ADJ
dpc-1329	31	51	kinase	kinase	ADJ
dpc-1329	31	52	inhibitor	inhibitor	NOUN
dpc-1329	31	53	sorafenib	sorafenib	PROPN
dpc-1329	31	54	.	.	PUNCT
dpc-1329	32	1	clin	clin	PROPN
dpc-1329	32	2	exp	exp	NOUN
dpc-1329	32	3	dermatol	dermatol	NOUN
dpc-1329	32	4	.	.	PUNCT
dpc-1329	33	1	2014;39(2):232	2014;39(2):232	NUM
dpc-1329	33	2	-	-	SYM
dpc-1329	33	3	233	233	NUM
dpc-1329	33	4	.	.	PUNCT
dpc-1329	34	1	doi	doi	NOUN
dpc-1329	34	2	:	:	PUNCT
dpc-1329	34	3	10.1111/	10.1111/	NUM
dpc-1329	34	4	ced.12257	ced.12257	NOUN
dpc-1329	34	5	.	.	PUNCT
dpc-1329	35	1	pmid	pmid	NOUN
dpc-1329	35	2	:	:	PUNCT
dpc-1329	35	3	24330088	24330088	NUM
dpc-1329	35	4	.	.	PUNCT
dpc-1329	36	1	2	2	X
dpc-1329	36	2	.	.	X
dpc-1329	36	3	borgia	borgia	PROPN
dpc-1329	36	4	f	f	PROPN
dpc-1329	36	5	,	,	PUNCT
dpc-1329	36	6	saitta	saitta	PROPN
dpc-1329	36	7	c	c	PROPN
dpc-1329	36	8	,	,	PUNCT
dpc-1329	36	9	vaccaro	vaccaro	PROPN
dpc-1329	36	10	m	m	PROPN
dpc-1329	36	11	,	,	PUNCT
dpc-1329	36	12	franzè	franzè	PROPN
dpc-1329	36	13	ms	ms	PROPN
dpc-1329	36	14	,	,	PUNCT
dpc-1329	36	15	lentini	lentini	PROPN
dpc-1329	36	16	m	m	PROPN
dpc-1329	36	17	,	,	PUNCT
dpc-1329	36	18	cannavò	cannavò	VERB
dpc-1329	36	19	sp	sp	NOUN
dpc-1329	36	20	.	.	PUNCT
dpc-1329	36	21	nodular	nodular	ADJ
dpc-1329	36	22	-	-	PUNCT
dpc-1329	36	23	cystic	cystic	ADJ
dpc-1329	36	24	eruption	eruption	NOUN
dpc-1329	36	25	in	in	ADP
dpc-1329	36	26	course	course	NOUN
dpc-1329	36	27	of	of	ADP
dpc-1329	36	28	sorafenib	sorafenib	PROPN
dpc-1329	36	29	administration	administration	NOUN
dpc-1329	36	30	for	for	ADP
dpc-1329	36	31	hepatocarcinoma	hepatocarcinoma	NOUN
dpc-1329	36	32	:	:	PUNCT
dpc-1329	36	33	an	an	DET
dpc-1329	36	34	unconventional	unconventional	ADJ
dpc-1329	36	35	skin	skin	NOUN
dpc-1329	36	36	reaction	reaction	NOUN
dpc-1329	36	37	requiring	require	VERB
dpc-1329	36	38	unconventional	unconventional	ADJ
dpc-1329	36	39	treatment	treatment	NOUN
dpc-1329	36	40	.	.	PUNCT
dpc-1329	37	1	int	int	PROPN
dpc-1329	37	2	j	j	PROPN
dpc-1329	37	3	immunopathol	immunopathol	PROPN
dpc-1329	37	4	pharmacol	pharmacol	PROPN
dpc-1329	37	5	.	.	PUNCT
dpc-1329	38	1	2017;30(3):327	2017;30(3):327	NUM
dpc-1329	38	2	-	-	SYM
dpc-1329	38	3	331	331	NUM
dpc-1329	38	4	.	.	PUNCT
dpc-1329	39	1	doi	doi	NOUN
dpc-1329	39	2	:	:	PUNCT
dpc-1329	39	3	10.1177/0394632017727618	10.1177/0394632017727618	NUM
dpc-1329	39	4	.	.	PUNCT
dpc-1329	40	1	pmid	pmid	NOUN
dpc-1329	40	2	:	:	PUNCT
dpc-1329	40	3	28825507	28825507	NUM
dpc-1329	40	4	.	.	PUNCT
dpc-1329	41	1	fusidic	fusidic	ADJ
dpc-1329	41	2	acid	acid	PROPN
dpc-1329	41	3	was	be	AUX
dpc-1329	41	4	prescribed	prescribe	VERB
dpc-1329	41	5	twice	twice	ADV
dpc-1329	41	6	a	a	DET
dpc-1329	41	7	day	day	NOUN
dpc-1329	41	8	.	.	PUNCT
dpc-1329	42	1	the	the	DET
dpc-1329	42	2	oncologist	oncologist	NOUN
dpc-1329	42	3	temporarily	temporarily	ADV
dpc-1329	42	4	discontinued	discontinue	VERB
dpc-1329	42	5	treatment	treatment	NOUN
dpc-1329	42	6	with	with	ADP
dpc-1329	42	7	sorafenib	sorafenib	NOUN
dpc-1329	42	8	 	 	SPACE
dpc-1329	42	9	due	due	ADP
dpc-1329	42	10	to	to	ADP
dpc-1329	42	11	liver	liver	NOUN
dpc-1329	42	12	 	 	SPACE
dpc-1329	42	13	decompensation	decompensation	NOUN
dpc-1329	42	14	.	.	PUNCT
dpc-1329	43	1	after	after	ADP
dpc-1329	43	2	1	1	NUM
dpc-1329	43	3	month	month	NOUN
dpc-1329	43	4	of	of	ADP
dpc-1329	43	5	sorafenib	sorafenib	PROPN
dpc-1329	43	6	interruption	interruption	NOUN
dpc-1329	43	7	,	,	PUNCT
dpc-1329	43	8	there	there	PRON
dpc-1329	43	9	was	be	VERB
dpc-1329	43	10	complete	complete	ADJ
dpc-1329	43	11	resolution	resolution	NOUN
dpc-1329	43	12	of	of	ADP
dpc-1329	43	13	the	the	DET
dpc-1329	43	14	eruption	eruption	NOUN
dpc-1329	43	15	with	with	ADP
dpc-1329	43	16	mild	mild	ADJ
dpc-1329	43	17	scarring	scarring	NOUN
dpc-1329	43	18	.	.	PUNCT
dpc-1329	44	1	conclusions	conclusion	NOUN
dpc-1329	44	2	five	five	NUM
dpc-1329	44	3	cases	case	NOUN
dpc-1329	44	4	of	of	ADP
dpc-1329	44	5	acne	acne	NOUN
dpc-1329	44	6	inversa	inversa	NOUN
dpc-1329	44	7	-	-	PUNCT
dpc-1329	44	8	like	like	ADJ
dpc-1329	44	9	lesions	lesion	NOUN
dpc-1329	44	10	associated	associate	VERB
dpc-1329	44	11	with	with	ADP
dpc-1329	44	12	sorafenib	sorafenib	NOUN
dpc-1329	44	13	have	have	AUX
dpc-1329	44	14	been	be	AUX
dpc-1329	44	15	reported	report	VERB
dpc-1329	44	16	,	,	PUNCT
dpc-1329	44	17	all	all	PRON
dpc-1329	44	18	of	of	ADP
dpc-1329	44	19	them	they	PRON
dpc-1329	44	20	in	in	ADP
dpc-1329	44	21	males	male	NOUN
dpc-1329	44	22	[	[	X
dpc-1329	44	23	1,2	1,2	NUM
dpc-1329	44	24	]	]	PUNCT
dpc-1329	44	25	.	.	PUNCT
dpc-1329	45	1	clinical	clinical	ADJ
dpc-1329	45	2	features	feature	NOUN
dpc-1329	45	3	 	 	SPACE
dpc-1329	45	4	of	of	ADP
dpc-1329	45	5	 	 	SPACE
dpc-1329	45	6	4	4	NUM
dpc-1329	45	7	of	of	ADP
dpc-1329	45	8	these	these	DET
dpc-1329	45	9	patients	patient	NOUN
dpc-1329	45	10	 	 	SPACE
dpc-1329	45	11	were	be	AUX
dpc-1329	45	12	similar	similar	ADJ
dpc-1329	45	13	to	to	ADP
dpc-1329	45	14	the	the	DET
dpc-1329	45	15	case	case	NOUN
dpc-1329	45	16	presented	present	VERB
dpc-1329	45	17	here	here	ADV
dpc-1329	45	18	,	,	PUNCT
dpc-1329	45	19	and	and	CCONJ
dpc-1329	45	20	except	except	SCONJ
dpc-1329	45	21	for	for	ADP
dpc-1329	45	22	1	1	NUM
dpc-1329	45	23	case	case	NOUN
dpc-1329	45	24	of	of	ADP
dpc-1329	45	25	classic	classic	ADJ
dpc-1329	45	26	hidradenitis	hidradenitis	NOUN
dpc-1329	45	27	suppurativa	suppurativa	NOUN
dpc-1329	45	28	located	locate	VERB
dpc-1329	45	29	in	in	ADP
dpc-1329	45	30	the	the	DET
dpc-1329	45	31	bilateral	bilateral	ADJ
dpc-1329	45	32	axillae	axillae	NOUN
dpc-1329	45	33	and	and	CCONJ
dpc-1329	45	34	inguinal	inguinal	ADJ
dpc-1329	45	35	region	region	NOUN
dpc-1329	45	36	,	,	PUNCT
dpc-1329	45	37	the	the	DET
dpc-1329	45	38	localization	localization	NOUN
dpc-1329	45	39	was	be	AUX
dpc-1329	45	40	atypical	atypical	ADJ
dpc-1329	45	41	in	in	ADP
dpc-1329	45	42	affecting	affect	VERB
dpc-1329	45	43	the	the	DET
dpc-1329	45	44	legs	leg	NOUN
dpc-1329	45	45	,	,	PUNCT
dpc-1329	45	46	abdomen	abdoman	NOUN
dpc-1329	45	47	,	,	PUNCT
dpc-1329	45	48	or	or	CCONJ
dpc-1329	45	49	buttocks	buttock	NOUN
dpc-1329	45	50	.	.	PUNCT
dpc-1329	46	1	histopathological	histopathological	ADJ
dpc-1329	46	2	analysis	analysis	NOUN
dpc-1329	46	3	showed	show	VERB
dpc-1329	46	4	comedone	comedone	NOUN
dpc-1329	46	5	-	-	PUNCT
dpc-1329	46	6	like	like	ADJ
dpc-1329	46	7	follicular	follicular	ADJ
dpc-1329	46	8	dilatation	dilatation	NOUN
dpc-1329	46	9	with	with	ADP
dpc-1329	46	10	perifollicular	perifollicular	ADJ
dpc-1329	46	11	lymphohistiocytic	lymphohistiocytic	ADJ
dpc-1329	46	12	infiltration	infiltration	NOUN
dpc-1329	46	13	.	.	PUNCT
dpc-1329	47	1	there	there	PRON
dpc-1329	47	2	appears	appear	VERB
dpc-1329	47	3	to	to	PART
dpc-1329	47	4	be	be	AUX
dpc-1329	47	5	a	a	DET
dpc-1329	47	6	dose	dose	NOUN
dpc-1329	47	7	-	-	PUNCT
dpc-1329	47	8	dependent	dependent	ADJ
dpc-1329	47	9	relationship	relationship	NOUN
dpc-1329	47	10	between	between	ADP
dpc-1329	47	11	sorafenib	sorafenib	NOUN
dpc-1329	47	12	and	and	CCONJ
dpc-1329	47	13	acneiform	acneiform	NOUN
dpc-1329	47	14	reaction	reaction	NOUN
dpc-1329	47	15	.	.	PUNCT
dpc-1329	48	1	except	except	SCONJ
dpc-1329	48	2	in	in	ADP
dpc-1329	48	3	1	1	NUM
dpc-1329	48	4	case	case	NOUN
dpc-1329	48	5	in	in	ADP
dpc-1329	48	6	which	which	PRON
dpc-1329	48	7	an	an	DET
dpc-1329	48	8	acne	acne	NOUN
dpc-1329	48	9	inversa	inversa	NOUN
dpc-1329	48	10	-	-	PUNCT
dpc-1329	48	11	like	like	ADJ
dpc-1329	48	12	eruption	eruption	NOUN
dpc-1329	48	13	resolved	resolve	VERB
dpc-1329	48	14	spontaneously	spontaneously	ADV
dpc-1329	48	15	,	,	PUNCT
dpc-1329	48	16	lesions	lesion	NOUN
dpc-1329	48	17	only	only	ADV
dpc-1329	48	18	improved	improve	VERB
dpc-1329	48	19	with	with	ADP
dpc-1329	48	20	dose	dose	NOUN
dpc-1329	48	21	reduction	reduction	NOUN
dpc-1329	48	22	or	or	CCONJ
dpc-1329	48	23	treatment	treatment	NOUN
dpc-1329	48	24	interruption	interruption	NOUN
dpc-1329	48	25	in	in	ADP
dpc-1329	48	26	combination	combination	NOUN
dpc-1329	48	27	with	with	ADP
dpc-1329	48	28	topical	topical	ADJ
dpc-1329	48	29	retinoids	retinoid	NOUN
dpc-1329	48	30	,	,	PUNCT
dpc-1329	48	31	antibiotics	antibiotic	NOUN
dpc-1329	48	32	,	,	PUNCT
dpc-1329	48	33	or	or	CCONJ
dpc-1329	48	34	benzoyl	benzoyl	NOUN
dpc-1329	48	35	peroxide	peroxide	NOUN
dpc-1329	48	36	[	[	X
dpc-1329	48	37	1,2	1,2	NUM
dpc-1329	48	38	]	]	PUNCT
dpc-1329	48	39	.	.	PUNCT
dpc-1329	49	1	if	if	SCONJ
dpc-1329	49	2	we	we	PRON
dpc-1329	49	3	apply	apply	VERB
dpc-1329	49	4	the	the	DET
dpc-1329	49	5	naranjo	naranjo	PROPN
dpc-1329	49	6	drug	drug	NOUN
dpc-1329	49	7	reaction	reaction	NOUN
dpc-1329	49	8	assessment	assessment	NOUN
dpc-1329	49	9	tool	tool	NOUN
dpc-1329	49	10	to	to	ADP
dpc-1329	49	11	this	this	DET
dpc-1329	49	12	case	case	NOUN
dpc-1329	49	13	,	,	PUNCT
dpc-1329	49	14	the	the	DET
dpc-1329	49	15	result	result	NOUN
dpc-1329	49	16	would	would	AUX
dpc-1329	49	17	be	be	AUX
dpc-1329	49	18	“	"	PUNCT
dpc-1329	49	19	probable	probable	ADJ
dpc-1329	49	20	.	.	PUNCT
dpc-1329	49	21	”	"	PUNCT
dpc-1329	50	1	unlike	unlike	ADP
dpc-1329	50	2	previously	previously	ADV
dpc-1329	50	3	reported	report	VERB
dpc-1329	50	4	cases	case	NOUN
dpc-1329	50	5	,	,	PUNCT
dpc-1329	50	6	our	our	PRON
dpc-1329	50	7	patient	patient	NOUN
dpc-1329	50	8	developed	develop	VERB
dpc-1329	50	9	acneiform	acneiform	ADJ
dpc-1329	50	10	lesions	lesion	NOUN
dpc-1329	50	11	while	while	SCONJ
dpc-1329	50	12	on	on	ADP
dpc-1329	50	13	a	a	DET
dpc-1329	50	14	low	low	ADJ
dpc-1329	50	15	dose	dose	NOUN
dpc-1329	50	16	of	of	ADP
dpc-1329	50	17	200	200	NUM
dpc-1329	50	18	mg	mg	NOUN
dpc-1329	50	19	twice	twice	DET
dpc-1329	50	20	a	a	DET
dpc-1329	50	21	day	day	NOUN
dpc-1329	50	22	.	.	PUNCT
dpc-1329	51	1	further	further	ADJ
dpc-1329	51	2	 	 	SPACE
dpc-1329	51	3	studies	study	NOUN
dpc-1329	51	4	are	be	AUX
dpc-1329	51	5	 	 	SPACE
dpc-1329	51	6	needed	need	VERB
dpc-1329	51	7	 	 	SPACE
dpc-1329	51	8	to	to	PART
dpc-1329	51	9	 	 	SPACE
dpc-1329	51	10	elucidate	elucidate	VERB
dpc-1329	51	11	the	the	DET
dpc-1329	51	12	pathogenic	pathogenic	ADJ
dpc-1329	51	13	explanation	explanation	NOUN
dpc-1329	51	14	and	and	CCONJ
dpc-1329	51	15	dose	dose	NOUN
dpc-1329	51	16	relationship	relationship	NOUN
dpc-1329	51	17	between	between	ADP
dpc-1329	51	18	sorafenib	sorafenib	NOUN
dpc-1329	51	19	and	and	CCONJ
dpc-1329	51	20	acne	acne	NOUN
dpc-1329	51	21	inversa	inversa	NOUN
dpc-1329	51	22	-	-	PUNCT
dpc-1329	51	23	like	like	ADJ
dpc-1329	51	24	lesions	lesion	NOUN
dpc-1329	51	25	.	.	PUNCT
dpc-1329	52	1	figure	figure	NOUN
dpc-1329	52	2	1	1	NUM
dpc-1329	52	3	.	.	PUNCT
dpc-1329	53	1	(	(	PUNCT
dpc-1329	53	2	a	a	DET
dpc-1329	53	3	,	,	PUNCT
dpc-1329	53	4	b	b	NOUN
dpc-1329	53	5	)	)	PUNCT
dpc-1329	53	6	two	two	NUM
dpc-1329	53	7	indurated	indurate	VERB
dpc-1329	53	8	erythematous	erythematous	ADJ
dpc-1329	53	9	plaques	plaque	NOUN
dpc-1329	53	10	with	with	ADP
dpc-1329	53	11	fistulous	fistulous	ADJ
dpc-1329	53	12	tracts	tract	NOUN
dpc-1329	53	13	and	and	CCONJ
dpc-1329	53	14	depressed	depressed	ADJ
dpc-1329	53	15	scar	scar	NOUN
dpc-1329	53	16	areas	area	NOUN
dpc-1329	53	17	on	on	ADP
dpc-1329	53	18	both	both	DET
dpc-1329	53	19	legs	leg	NOUN
dpc-1329	53	20	.	.	PUNCT
dpc-1329	54	1	figure	figure	NOUN
dpc-1329	54	2	2	2	NUM
dpc-1329	54	3	.	.	PUNCT
dpc-1329	55	1	(	(	PUNCT
dpc-1329	55	2	a	a	X
dpc-1329	55	3	)	)	PUNCT
dpc-1329	55	4	perifollicular	perifollicular	ADJ
dpc-1329	55	5	and	and	CCONJ
dpc-1329	55	6	perivascular	perivascular	ADJ
dpc-1329	55	7	lymphohistiocytic	lymphohistiocytic	ADJ
dpc-1329	55	8	infiltration	infiltration	NOUN
dpc-1329	55	9	(	(	PUNCT
dpc-1329	55	10	h&e	h&e	PROPN
dpc-1329	55	11	,	,	PUNCT
dpc-1329	55	12	×20	×20	PROPN
dpc-1329	55	13	)	)	PUNCT
dpc-1329	55	14	.	.	PUNCT
dpc-1329	56	1	(	(	PUNCT
dpc-1329	56	2	b	b	X
dpc-1329	56	3	)	)	PUNCT
dpc-1329	56	4	dilated	dilate	VERB
dpc-1329	56	5	follicular	follicular	ADJ
dpc-1329	56	6	infundibula	infundibula	NOUN
dpc-1329	56	7	filled	fill	VERB
dpc-1329	56	8	with	with	ADP
dpc-1329	56	9	compact	compact	ADJ
dpc-1329	56	10	parakeratotic	parakeratotic	ADJ
dpc-1329	56	11	cornified	cornifie	VERB
dpc-1329	56	12	cells	cell	NOUN
dpc-1329	56	13	and	and	CCONJ
dpc-1329	56	14	neutrophils	neutrophil	NOUN
dpc-1329	56	15	(	(	PUNCT
dpc-1329	56	16	h&e	h&e	PROPN
dpc-1329	56	17	,	,	PUNCT
dpc-1329	56	18	×100	×100	PROPN
dpc-1329	56	19	)	)	PUNCT
dpc-1329	56	20	.	.	PUNCT